Page last updated: 2024-08-25

voriconazole and anidulafungin

voriconazole has been researched along with anidulafungin in 106 studies

Research

Studies (106)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (1.89)	18.2507
2000's	30 (28.30)	29.6817
2010's	64 (60.38)	24.3611
2020's	10 (9.43)	2.80

Authors

Authors	Studies
Chatzimoschou, A; Dalakiouridou, M; Diza-Mataftsi, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Tsantali, C	1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL	1
Dierich, MP; Jost, D; Lass-Flörl, C; Perkhofer, S	1
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS	1
Jacobson, MJ; Nguyen, G; Patel, R; Piper, KE; Steckelberg, JM	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chu, CC; Hsueh, PR; Ruan, SY	1
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS	1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL	1
Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N	1
Dimopoulos, G; Falagas, ME; Velegraki, A	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM	1
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE	1
Banevicius, MA; Crandon, JL; Crownover, PH; Fang, AF; Knauft, RF; Kuti, JL; Nicolau, DP; Pope, JS; Russomanno, JH; Shore, E	1
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ	1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Baquero, F	1
Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A	1
Chiou, CC; Groll, AH; Walsh, TJ	1
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A	1
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J	1
Gupta, AK; Tomas, E	1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR	1
Steinbach, WJ	1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J	1
Baker, CJ; Pannaraj, PS; Walsh, TJ	1
Baruch, A; Dowell, JA; Foster, G; Schranz, J	1
Bernhardt, H; Knoke, M	1
Cubillos, GF; Kett, DH	1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W	1
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ	1
Lass-Flörl, C; Perkhofer, S	1
Chatzimoschou, A; Cotten, CJ; Diza-Mataftsi, E; Katragkou, A; Kruhlak, MJ; Paliogianni, F; Roilides, E; Simitsopoulou, M; Taparkou, A; Tsantali, C; Walsh, TJ	1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA	1
Castanheira, M; Jones, RN; Pfaller, MA	1
Aznar, J; de Toro, M; Maite, R; Torres, MJ	1
Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B	1
Heijink, A; Patel, R; Rouse, MS; Steckelberg, JM	1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR	1
De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M	1
Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ	1
George, J; Reboli, AC	1
Bernhardt, H; Bernhardt, J; Knoke, M	1
Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA	1
Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V	1
Bowman, CJ; Chmielewski, G; Cross, DM; Lewis, EM; Liu, L; Modesitt, MS; Ripp, SL; Sawaryn, CM	1
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G	1
Alou, L; Cafini, F; Corcuera, MT; Gómez-Aguado, F; González, N; Guinea, J; Prieto, J; Sevillano, D	1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC	1
Andersen, N; Baltch, AL; Bopp, LH; Carlyn, CJ; Lawrence, D; Michelsen, PB; Ritz, WJ; Smith, RP	1
Chandrasekar, PH; Krishnan-Natesan, S; Wu, W	1
Alanio, A; Bougnoux, ME; Dannaoui, E; Ducroz, S; Lortholary, O; Planche, V	1
Al-Nakeeb, Z; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Warn, PA	1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE	1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE	1
Melchers, WJ; Meletiadis, J; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE	1
Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL	1
Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A	1
Co, VM; Hsueh, PR; Mootsikapun, P; Ong, ML; Rajadhyaksha, V; Talwar, D	1
Abreu, P; Colombo, AL; Magana, M; Nucci, M; Petti, M; Sanchez, SP; Schlamm, HT	1
Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA	1
Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D	1
Biswas, P; Chin-Hong, P; Kett, DH; Pappas, PG; Patterson, TF; Reboli, AC; Reinhardt, J; Swanson, R; Tobin, E; Vazquez, J	1
Baliellas, C; Bodro, M; Carratalà, J; Fabregat, J; Lladó, L; Petit, A; Ramos, E; Sabé, N; Solé, C	1
Schnadig, VJ; Shah, SK; Terasaki, JM; Valentine, VG	1
Liu, P; Mould, DR	2
Bow, EJ; Cornely, OA; Heinz, WJ; Herbrecht, R; Jagannatha, S; Koh, LP; Kontoyiannis, DP; Lee, DG; Maertens, JA; Marr, KA; Nucci, M; Pappas, PG; Queiroz-Telles, F; Rottinghaus, ST; Schlamm, HT; Selleslag, D; Slavin, MA; Walsh, TJ; Wingard, JR	1
Cotton, D	1
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R	1
Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA	1
Peghin, M; Ruiz-Camps, I	1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF	1
Carbajal, WH; Lozada, C; Reyes, HA; Valdez, LM	1
Antachopoulos, C; Chatzimoschou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ	1
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S	1
Akoumianaki, T; Albert, N; Andrianaki, A; Chamilos, G; Ioannou, P; Kontoyiannis, DP; Kyrmizi, I; Perlin, D; Samonis, G	1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C	1
Cadirci, E; Duzgun, E; Karagoz, E; Keles, S; Turhan, V; Ugan, RA; Uyanik, MH; Yavan, I	1
Ahmad, N; Ginsapu, SJ; Gowbei, A; Hashim, R; Ho Betty, LS; Ramli, NY; Razak, MF; Sabaratnam, P; Sipiczki, M; Suppiah, J; Tap, RM	1
Hsueh, PR; Wang, H; Xu, YC	1
Capilla, J; Guarro, J; Martin-Vicente, A	1
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E	1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K	1
Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L	1
Alexander, BD; Borroto-Esoda, K; Jones, AM; Schell, WA	1
Cai, WP; Chen, WS; Chen, XJ; He, Y; Hu, FY; Lei, HL; Li, LH; Song, WN; Tang, XP	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Chaftari, AM; Hachem, R; Kontoyiannis, DP; Raad, II; Reitzel, RA; Rosenblatt, J; Vargas-Cruz, N; Wilson Dib, R	1
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X	1
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL	1
Corcione, S; D'Avolio, A; De Rosa, FG; Pagani, N; Pasero, D; Sanguinetti, M; Trentalange, A	1
Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J	1
Bot, JCJ; de Leeuw, DC; Hendriks, EJ; Overgaauw, AJC; Stoof, SP; van Dijk, K	1
Aram, JA; Busca, A; Capparella, MR; De Rosa, FG; Yan, JL	1
Brandão, IB; Colombo, AL; de Almeida, SLR; de Andrade, TS; de Miranda Costa, MM; de Oliveira Dias, P; de Souza Jordão, RT; Francisco, EC; Meis, JF; Nobrega de Almeida, J; Pereira, FM; Santos Ferreira, F	1
Castanheira, M; Deshpande, LM; Messer, SA; Pfaller, MA; Rhomberg, PR; Utt, EA	1
Chen, H; Chen, X; Deng, S; Hong, N; Hu, D; Lei, Y; Liao, W; Tsui, KM; Wu, G; Yan, L; Yu, N; Zhang, H; Zhao, R	1
Hamor, RE; Martinez, PS; Plummer, CE; Richardson, RL; Wellehan, JFX; Whitley, RD	1
Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A	1
Aksaray, S; Turan, D	1
He, C; Kang, W; Li, J; Wang, T; Xu, Y; Yu, J; Zhang, G; Zhang, J; Zhao, Y	1

Reviews

11 review(s) available for voriconazole and anidulafungin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. The oncologist, 2000, Volume: 5, Issue:2 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2000
New antifungal agents. Dermatologic clinics, 2003, Volume: 21, Issue:3 Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2003
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Anidulafungin in the treatment of patients with invasive candidiasis. International journal of antimicrobial agents, 2008, Volume: 32 Suppl 2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole	2008
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Expert opinion on investigational drugs, 2009, Volume: 18, Issue:9 Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2009
Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2010
Anidulafungin: when and how? The clinician's view. Mycoses, 2012, Volume: 55, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
[Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatment]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28 Suppl 1 Topics: Anidulafungin; Antifungal Agents; Drug Combinations; Echinocandins; Fungi; Humans; Immunocompromised Host; Immunosuppression Therapy; Mycoses; Voriconazole	2015
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future microbiology, 2016, Volume: 11 Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole	2016
Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies. Clinical drug investigation, 2021, Volume: 41, Issue:6 Topics: Administration, Intravenous; Anidulafungin; Antifungal Agents; Candidemia; Candidiasis, Invasive; Fluconazole; Humans; Neoplasms; Treatment Outcome; Voriconazole	2021

Trials

10 trial(s) available for voriconazole and anidulafungin

Article	Year
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Adult; Anidulafungin; Antifungal Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Echinocandins; Female; Humans; Injections, Intravenous; Male; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole; Young Adult	2009
Safety and pharmacokinetics of coadministered voriconazole and anidulafungin. Journal of clinical pharmacology, 2005, Volume: 45, Issue:12 Topics: Adult; Anidulafungin; Antifungal Agents; Cross-Over Studies; Drug Therapy, Combination; Echinocandins; Humans; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2012
Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial. BMC infectious diseases, 2013, May-15, Volume: 13 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Anidulafungin; Antifungal Agents; Candidemia; Echinocandins; Female; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2013
An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America. Mycoses, 2014, Volume: 57, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Echinocandins; Female; Humans; Latin America; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial. BMC infectious diseases, 2014, Feb-21, Volume: 14 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Candidiasis, Invasive; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Republic of Korea; Research Design; Risk; Treatment Outcome; United States; Voriconazole; Young Adult	2014
Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Body Weight; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Models, Statistical; Prospective Studies; Voriconazole	2014
Combination antifungal therapy for invasive aspergillosis: a randomized trial. Annals of internal medicine, 2015, Jan-20, Volume: 162, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Male; Mannans; Middle Aged; Platelet Count; Treatment Outcome; Voriconazole; Young Adult	2015
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data. BMC infectious diseases, 2019, May-28, Volume: 19, Issue:1 Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole	2019
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis. Mycoses, 2019, Volume: 62, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult	2019

Other Studies

85 other study(ies) available for voriconazole and anidulafungin

Article	Year
Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1 Topics: Antifungal Agents; Azoles; Biofilms; Candida; Candida albicans; Echinocandins; Humans; Microbial Sensitivity Tests	2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity	2008
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Anaerobiosis; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Echinocandins; Hyphae; Microbial Sensitivity Tests; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole	2008
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation	2008
In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny	2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged	2008
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology	2009
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction	2009
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain	2009
Anidulafungin treatment of candidal central nervous system infection in a murine model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole	2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia	2009
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2010
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole	2010
[Antifungal drugs: the new frontier]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole	1998
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5 Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	1999
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:2 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole	2003
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagnostic microbiology and infectious disease, 2003, Volume: 46, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole	2003
In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Advances in antifungal therapy. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole	2005
[What distinctions do Candida biofilms have to offer?]. Mycoses, 2008, Volume: 51 Suppl 3 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Culture Media; Drug Resistance, Fungal; Echinocandins; Glucose; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2008
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole	2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole	2009
Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. The Journal of infectious diseases, 2010, Jun-15, Volume: 201, Issue:12 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Cytokines; Echinocandins; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Microbial Viability; Microscopy, Confocal; Oxidation-Reduction; Phagocytes; Pyrimidines; Respiratory Burst; Rhodamines; Staining and Labeling; Triazoles; Voriconazole	2010
Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2010
Characterization of Candida parapsilosis complex isolates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole	2011
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole	2010
Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clinical orthopaedics and related research, 2011, Volume: 469, Issue:5 Topics: Anidulafungin; Antifungal Agents; Drug Carriers; Drug Implants; Echinocandins; Polymethyl Methacrylate; Pyrimidines; Solubility; Time Factors; Triazoles; Voriconazole	2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Clinical experience of anidulafungin for the treatment of patients with documented candidemia. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Italy; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2010
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole	2011
Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation. Mycoses, 2011, Volume: 54, Issue:6 Topics: Aerobiosis; Anaerobiosis; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11 Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2012
Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus. Mycopathologia, 2012, Volume: 173, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Drug Therapy, Combination; Echinocandins; Humans; Male; Mice; Pyrimidines; Triazoles; Voriconazole	2012
Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan. Regulatory toxicology and pharmacology : RTP, 2012, Volume: 63, Issue:1 Topics: Administration, Oral; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Drug Combinations; Drug Evaluation, Preclinical; Echinocandins; Female; Injections, Subcutaneous; Male; Pyrimidines; Rats; Rats, Inbred F344; Research Design; Sex Factors; Toxicity Tests; Triazoles; Voriconazole	2012
Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Colorimetry; Culture Media; Drug Combinations; Echinocandins; Humans; Microbial Sensitivity Tests; Protein Binding; Pyrimidines; Serum Albumin; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole	2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide. Chemotherapy, 2012, Volume: 58, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Chemokines; Cytokines; Echinocandins; Humans; Lipopolysaccharides; Macrophages; Pyrimidines; Triazoles; Voriconazole	2012
In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus. Diagnostic microbiology and infectious disease, 2012, Volume: 73, Issue:2 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Azoles; Drug Combinations; Echinocandins; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cell Line; Chromatography, High Pressure Liquid; Drug Interactions; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Models, Theoretical; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole	2012
Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Echinocandins; Female; Fungal Proteins; Humans; Mice; Mutation; Neutrophils; Promoter Regions, Genetic; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2013
Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Mice; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2013
In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Microbial Sensitivity Tests; Point Mutation; Promoter Regions, Genetic; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole	2013
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole	2013
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2013
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole	2013
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2014
Candida arteritis occurring in a liver transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:3 Topics: Anidulafungin; Antifungal Agents; Arteritis; Candidiasis; Echinocandins; Fatal Outcome; Graft Rejection; Humans; Liver Transplantation; Male; Middle Aged; Voriconazole	2014
Airway complication contributing to disseminated fusariosis after lung transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:4 Topics: Aged; Anidulafungin; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Female; Fusariosis; Fusarium; Humans; Lung Diseases, Fungal; Lung Transplantation; Voriconazole	2014
Population pharmacokinetic-pharmacodynamic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Chemical and Drug Induced Liver Injury; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Hallucinations; Humans; Male; Middle Aged; Models, Statistical; Photophobia; Prospective Studies; Voriconazole	2014
Celebrating the ACP centennial: from the annals archive. Annals of internal medicine, 2015, Jan-20, Volume: 162, Issue:2 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Voriconazole	2015
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses, 2015, Volume: 58, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole	2015
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution. BMC infectious diseases, 2015, Jul-03, Volume: 15 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole	2015
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient. BMJ case reports, 2015, Oct-09, Volume: 2015 Topics: Adult; Anidulafungin; Antifungal Agents; Aorta; Candida; Candidiasis; Cross Infection; Echinocandins; Echocardiography; Endocarditis; Female; Humans; Immunocompromised Host; Ovarian Neoplasms; Voriconazole	2015
Differential effects of antifungal agents on expression of genes related to formation of Candida albicans biofilms. Mycoses, 2016, Volume: 59, Issue:1 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Down-Regulation; Echinocandins; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Up-Regulation; Voriconazole	2016
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses. Mycopathologia, 2016, Volume: 181, Issue:3-4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae. Antimicrobial agents and chemotherapy, 2015, Dec-07, Volume: 60, Issue:3 Topics: Albumins; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Culture Media; Echinocandins; Humans; Hyphae; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole	2015
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole	2016
A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model. Current eye research, 2017, Volume: 42, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Intravitreal Injections; Iris; Male; Rabbits; Vitreous Body; Voriconazole	2017
First isolation of Candida wangnamkhiaoensis from the blood of immunocompromised paediatric patient. Mycoses, 2016, Volume: 59, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Caspofungin; Child, Preschool; DNA, Ribosomal Spacer; Echinocandins; Fluconazole; Humans; Hyphae; Immunocompromised Host; Lipopeptides; Male; Phylogeny; Polymerase Chain Reaction; Sequence Alignment; Voriconazole	2016
Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation. International journal of antimicrobial agents, 2017, Volume: 49, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Drug Synergism; Echinocandins; Voriconazole	2017
New pharmacological opportunities for the treatment of invasive mould diseases. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole	2017
Changing epidemiology of candidaemia in Australia. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2017
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes. PloS one, 2017, Volume: 12, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult	2017
Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Glycosides; Humans; Microbial Sensitivity Tests; Triterpenes; Voriconazole	2017
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:6 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Echinocandins; HIV Infections; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Reagent Kits, Diagnostic; Talaromyces; Voriconazole	2018
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Caspofungin; Catheter-Related Infections; Catheters; Citric Acid; Ethanol; Fluconazole; Micafungin; Nitroglycerin; Pharmaceutical Solutions; Voriconazole	2019
Acquisition of FKS2 mutation after echinocandin treatment of infective endocarditis by Candida glabrata. Le infezioni in medicina, 2019, Sep-01, Volume: 27, Issue:3 Topics: Aged; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Candidiasis; Endocarditis; Female; Fungal Proteins; Heart Valve Prosthesis Implantation; Humans; Microbial Sensitivity Tests; Point Mutation; Voriconazole	2019
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method. The Journal of antimicrobial chemotherapy, 2020, 05-01, Volume: 75, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole	2020
Case report: Candida krusei spondylitis in an immunocompromised patient. BMC infectious diseases, 2020, Oct-08, Volume: 20, Issue:1 Topics: Aged; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Humans; Immunocompromised Host; Induction Chemotherapy; Male; Micafungin; Spondylitis; Treatment Outcome; Voriconazole	2020
Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil. Mycoses, 2021, Volume: 64, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Brazil; Candida; Candidiasis; COVID-19; Critical Care; Disease Outbreaks; Disease Transmission, Infectious; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; SARS-CoV-2; Thermometers; Voriconazole	2021
Antifungal drugs work together to treat germs causing fungal infections. Future microbiology, 2021, Volume: 16 Topics: Anidulafungin; Antifungal Agents; Candida auris; Candidiasis, Invasive; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Nitriles; Pyridines; Triazoles; Voriconazole	2021
Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China. Mycopathologia, 2022, Volume: 187, Issue:2-3 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Microbial Sensitivity Tests; Voriconazole	2022
In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis. Veterinary ophthalmology, 2022, Volume: 25, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Horses; Microbial Sensitivity Tests; Natamycin; Voriconazole	2022
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates. Mycoses, 2022, Volume: 65, Issue:11 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole	2022
[One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?] Mikrobiyoloji bulteni, 2022, Volume: 56, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Microbial Sensitivity Tests; Mycology; Voriconazole	2022
Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics. Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Fluconazole; Micafungin; Microbial Sensitivity Tests; Reproducibility of Results; Voriconazole; Yeasts	2023